Illinois General Assembly - Full Text of HB2446
Illinois General Assembly

Previous General Assemblies

Full Text of HB2446  96th General Assembly

HB2446 96TH GENERAL ASSEMBLY


 


 
96TH GENERAL ASSEMBLY
State of Illinois
2009 and 2010
HB2446

 

Introduced 2/19/2009, by Rep. Kathleen A. Ryg

 

SYNOPSIS AS INTRODUCED:
 
405 ILCS 5/2-107.1   from Ch. 91 1/2, par. 2-107.1

    Amends the Mental Health and Developmental Disabilities Code. Provides that a court order authorizing the administration of authorized involuntary treatment shall allow a person designated in the order as authorized to administer the treatment to designate another person to administer the treatment in the court-designated person's absence. Provides that a person designated in the court order as authorized to administer the treatment must be a qualified acute and long-term health care professional familiar with the recipient's mental and physical status and active in the recipient's care. Provides that a person designated by the court-designated person to administer the treatment in the court-designated person's absence must be a licensed and qualified health care professional. Effective immediately.


LRB096 08383 DRJ 18495 b

FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB2446 LRB096 08383 DRJ 18495 b

1     AN ACT concerning health.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Mental Health and Developmental
5 Disabilities Code is amended by changing Section 2-107.1 as
6 follows:
 
7     (405 ILCS 5/2-107.1)  (from Ch. 91 1/2, par. 2-107.1)
8     Sec. 2-107.1. Administration of psychotropic medication
9 and electroconvulsive therapy upon application to a court.
10     (a) (Blank).
11     (a-5) Notwithstanding the provisions of Section 2-107 of
12 this Code, psychotropic medication and electroconvulsive
13 therapy may be administered to an adult recipient of services
14 without the informed consent of the recipient under the
15 following standards:
16         (1) Any person 18 years of age or older, including any
17     guardian, may petition the circuit court for an order
18     authorizing the administration of psychotropic medication
19     and electroconvulsive therapy to a recipient of services.
20     The petition shall state that the petitioner has made a
21     good faith attempt to determine whether the recipient has
22     executed a power of attorney for health care under the
23     Powers of Attorney for Health Care Law or a declaration for

 

 

HB2446 - 2 - LRB096 08383 DRJ 18495 b

1     mental health treatment under the Mental Health Treatment
2     Preference Declaration Act and to obtain copies of these
3     instruments if they exist. If either of the above-named
4     instruments is available to the petitioner, the instrument
5     or a copy of the instrument shall be attached to the
6     petition as an exhibit. The petitioner shall deliver a copy
7     of the petition, and notice of the time and place of the
8     hearing, to the respondent, his or her attorney, any known
9     agent or attorney-in-fact, if any, and the guardian, if
10     any, no later than 3 days prior to the date of the hearing.
11     Service of the petition and notice of the time and place of
12     the hearing may be made by transmitting them via facsimile
13     machine to the respondent or other party. Upon receipt of
14     the petition and notice, the party served, or the person
15     delivering the petition and notice to the party served,
16     shall acknowledge service. If the party sending the
17     petition and notice does not receive acknowledgement of
18     service within 24 hours, service must be made by personal
19     service.
20         The petition may include a request that the court
21     authorize such testing and procedures as may be essential
22     for the safe and effective administration of the
23     psychotropic medication or electroconvulsive therapy
24     sought to be administered, but only where the petition sets
25     forth the specific testing and procedures sought to be
26     administered.

 

 

HB2446 - 3 - LRB096 08383 DRJ 18495 b

1         If a hearing is requested to be held immediately
2     following the hearing on a petition for involuntary
3     admission, then the notice requirement shall be the same as
4     that for the hearing on the petition for involuntary
5     admission, and the petition filed pursuant to this Section
6     shall be filed with the petition for involuntary admission.
7         (2) The court shall hold a hearing within 7 days of the
8     filing of the petition. The People, the petitioner, or the
9     respondent shall be entitled to a continuance of up to 7
10     days as of right. An additional continuance of not more
11     than 7 days may be granted to any party (i) upon a showing
12     that the continuance is needed in order to adequately
13     prepare for or present evidence in a hearing under this
14     Section or (ii) under exceptional circumstances. The court
15     may grant an additional continuance not to exceed 21 days
16     when, in its discretion, the court determines that such a
17     continuance is necessary in order to provide the recipient
18     with an examination pursuant to Section 3-803 or 3-804 of
19     this Act, to provide the recipient with a trial by jury as
20     provided in Section 3-802 of this Act, or to arrange for
21     the substitution of counsel as provided for by the Illinois
22     Supreme Court Rules. The hearing shall be separate from a
23     judicial proceeding held to determine whether a person is
24     subject to involuntary admission but may be heard
25     immediately preceding or following such a judicial
26     proceeding and may be heard by the same trier of fact or

 

 

HB2446 - 4 - LRB096 08383 DRJ 18495 b

1     law as in that judicial proceeding.
2         (3) Unless otherwise provided herein, the procedures
3     set forth in Article VIII of Chapter 3 of this Act,
4     including the provisions regarding appointment of counsel,
5     shall govern hearings held under this subsection (a-5).
6         (4) Psychotropic medication and electroconvulsive
7     therapy may be administered to the recipient if and only if
8     it has been determined by clear and convincing evidence
9     that all of the following factors are present. In
10     determining whether a person meets the criteria specified
11     in the following paragraphs (A) through (G), the court may
12     consider evidence of the person's history of serious
13     violence, repeated past pattern of specific behavior,
14     actions related to the person's illness, or past outcomes
15     of various treatment options.
16             (A) That the recipient has a serious mental illness
17         or developmental disability.
18             (B) That because of said mental illness or
19         developmental disability, the recipient currently
20         exhibits any one of the following: (i) deterioration of
21         his or her ability to function, as compared to the
22         recipient's ability to function prior to the current
23         onset of symptoms of the mental illness or disability
24         for which treatment is presently sought, (ii)
25         suffering, or (iii) threatening behavior.
26             (C) That the illness or disability has existed for

 

 

HB2446 - 5 - LRB096 08383 DRJ 18495 b

1         a period marked by the continuing presence of the
2         symptoms set forth in item (B) of this subdivision (4)
3         or the repeated episodic occurrence of these symptoms.
4             (D) That the benefits of the treatment outweigh the
5         harm.
6             (E) That the recipient lacks the capacity to make a
7         reasoned decision about the treatment.
8             (F) That other less restrictive services have been
9         explored and found inappropriate.
10             (G) If the petition seeks authorization for
11         testing and other procedures, that such testing and
12         procedures are essential for the safe and effective
13         administration of the treatment.
14         (5) In no event shall an order issued under this
15     Section be effective for more than 90 days. A second 90-day
16     period of involuntary treatment may be authorized pursuant
17     to a hearing that complies with the standards and
18     procedures of this subsection (a-5). Thereafter,
19     additional 180-day periods of involuntary treatment may be
20     authorized pursuant to the standards and procedures of this
21     Section without limit. If a new petition to authorize the
22     administration of psychotropic medication or
23     electroconvulsive therapy is filed at least 15 days prior
24     to the expiration of the prior order, and if any
25     continuance of the hearing is agreed to by the recipient,
26     the administration of the treatment may continue in

 

 

HB2446 - 6 - LRB096 08383 DRJ 18495 b

1     accordance with the prior order pending the completion of a
2     hearing under this Section.
3         (6) An order issued under this subsection (a-5) shall
4     designate the persons authorized to administer the
5     treatment under the standards and procedures of this
6     subsection (a-5) and shall allow any of those persons to
7     designate one or more other persons to administer the
8     treatment in the court-designated person's absence. Those
9     persons shall have complete discretion not to administer
10     any treatment authorized under this Section. The order
11     shall also specify the medications and the anticipated
12     range of dosages that have been authorized and may include
13     a list of any alternative medications and range of dosages
14     deemed necessary. A person designated in the court order as
15     authorized to administer the treatment must be a qualified
16     acute and long-term health care professional familiar with
17     the recipient's mental and physical status and active in
18     the recipient's care. A person designated by a
19     court-designated person to administer the treatment in the
20     court-designated person's absence must be a licensed and
21     qualified health care professional.
22     (a-10) The court may, in its discretion, appoint a guardian
23 ad litem for a recipient before the court or authorize an
24 existing guardian of the person to monitor treatment and
25 compliance with court orders under this Section.
26     (b) A guardian may be authorized to consent to the

 

 

HB2446 - 7 - LRB096 08383 DRJ 18495 b

1 administration of psychotropic medication or electroconvulsive
2 therapy to an objecting recipient only under the standards and
3 procedures of subsection (a-5).
4     (c) Notwithstanding any other provision of this Section, a
5 guardian may consent to the administration of psychotropic
6 medication or electroconvulsive therapy to a non-objecting
7 recipient under Article XIa of the Probate Act of 1975.
8     (d) Nothing in this Section shall prevent the
9 administration of psychotropic medication or electroconvulsive
10 therapy to recipients in an emergency under Section 2-107 of
11 this Act.
12     (e) Notwithstanding any of the provisions of this Section,
13 psychotropic medication or electroconvulsive therapy may be
14 administered pursuant to a power of attorney for health care
15 under the Powers of Attorney for Health Care Law or a
16 declaration for mental health treatment under the Mental Health
17 Treatment Preference Declaration Act.
18     (f) The Department shall conduct annual trainings for
19 physicians and registered nurses working in State-operated
20 mental health facilities on the appropriate use of psychotropic
21 medication and electroconvulsive therapy, standards for their
22 use, and the preparation of court petitions under this Section.
23 (Source: P.A. 94-1066, eff. 8-1-06; 95-172, eff. 8-14-07.)
 
24     Section 99. Effective date. This Act takes effect upon
25 becoming law.